ArticleJournal of global health2026
When more diagnoses do not mean more disease: a data-driven reassessment of global chronic disease trends, 2011-2025.
Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rising global numbers of chronic noncommunicable diseases (NCDs) are commonly interpreted as evidence of a growing epidemic. In 2011, we hypothesised that this perception is partly driven by population ageing, expanding diagnostic criteria, and improved detection rather than a uniform increase in underlying biological risk. This study reassesses that hypothesis using contemporary global data. Methods: We conducted a descriptive, comparative epidemiological analysis using publicly available data sets from the Global Burden of Disease, World Health Organization Global Health Estimates, and the International Diabetes Federation. Absolute case counts and deaths were analysed alongside age-standardised mortality rates to distinguish demographic effects (population growth and ageing), diagnostic expansion, and changes in underlying risk. Trends were evaluated relative to 1990 and 2011 baselines. Results: Absolute numbers of cases and deaths from major NCDs have continued to rise globally, largely reflecting population growth and ageing. In contrast, age-standardised mortality rates have declined substantially for cardiovascular disease and chronic obstructive pulmonary disease and have stabilised for other conditions. This divergence between increasing absolute burden and stable or declining age-specific risk is consistent across major diseases. Expanded diagnostic criteria, improved detection, and increased survival have further contributed to rising prevalence, particularly in older populations. Conclusions: Rising absolute counts of NCDs are largely explained by demographic change and diagnostic expansion, while age-standardised trends suggest stable or declining risk for several major conditions. These findings support a more nuanced interpretation of global chronic disease trends, integrating demographic, diagnostic, and risk-factor perspectives. Careful use of age-standardised measures alongside absolute counts is essential for accurate monitoring and for informing public health priorities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.